QA: ENDONOVO THERAPEUTICS INC. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001528172_2019_ENDONOVO_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001528172')"}

Graph

Absolute values for 0001528172, ENDONOVO THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 382,496
1 IntangibleAssetsNetIncludingGoodwill 3,853,090
2 PropertyPlantAndEquipmentNet 6,727
3 remainder_Assets 0
4 LiabilitiesCurrent 15,479,151
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 155,000
7 CostOfGoodsAndServicesSold 12,930
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 4,229,595
11 remainder_Revenues 83,263
12 remainder_NetIncome -2,276,577
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 4,242,313
1 Liabilities 15,634,151
2 Expenses 4,242,525
3 Revenues 83,263
4 StockholdersEquity -11,391,838
5 NetIncome -6,435,839
6 ComprehensiveNetIncome -6,435,839
7 BaseVar 13,239,414
8 EconomicCapitalRatio -2.62

Edgar->Model Mapping

Feature Distribution

Change over Time